Intuitive Surgical (ISRG)
(Delayed Data from NSDQ)
$506.34 USD
+2.50 (0.50%)
Updated Nov 1, 2024 03:59 PM ET
After-Market: $506.75 +0.41 (0.08%) 7:58 PM ET
2-Buy of 5 2
D Value C Growth B Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$506.34 USD
+2.50 (0.50%)
Updated Nov 1, 2024 03:59 PM ET
After-Market: $506.75 +0.41 (0.08%) 7:58 PM ET
2-Buy of 5 2
D Value C Growth B Momentum C VGM
Zacks News
Varian Medical Initiates Treatment Using Halcyon System
by Zacks Equity Research
Varian Medical (VAR) has been taking initiatives to gain customers for its broad spectrum of products.
Mazor Robotics Gets CE Mark for Surgical Assurance Platform
by Zacks Equity Research
Earlier this year, Mazor Robotics (MZOR) had announced the receipt of FDA clearance for its Mazor X Align software.
Intuitive Surgical (ISRG) Well Poised on Procedural Business
by Zacks Equity Research
Intuitive Surgical's (ISRG) strong sales growth will continue to be aided by focus on da Vinci system and procedural growth from general surgery, oncology, urology and gynecology.
Intuitive Surgical at 52-Week High: What's Driving the Stock?
by Zacks Equity Research
Share price of Intuitive Surgical (ISRG) reaches a new 52-week high on the back of its new partnership and impressive second-quarter performance.
The Zacks Analyst Blog Highlights: Facebook, Air Liquide and Intuitive Surgical
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Facebook, Air Liquide and Intuitive Surgical
Watch Out for the Three Stooges: Global Week Ahead
by John Blank
Q2's biggest earnings week, minutes from the latest FOMC meeting and U.S. GDP Friday may be the Three Musketeers charging markets higher... or, they may become the Three Stooges instead.
Intuitive Surgical (ISRG) Beats on Q2 Earnings & Revenues
by Zacks Equity Research
Intuitive Surgical posted solid numbers in the quarter under review, courtesy of rising customer adoption of procedures and growth in system placements.
Medical Product Stocks' Earnings on Jul 20: ABT, ISRG & More
by Zacks Equity Research
The market remained jittery towards medical space due to uncertainties surrounding the future of the healthcare act.
4 Healthcare Megatrends for Investors
by Kevin Cook
One sector combines the best of science and technology with our dreams for healthier and wealthier lives.
Will Intuitive Surgical (ISRG) Surprise in Q2 Earnings?
by Zacks Equity Research
Intuitive Surgical Inc. (ISRG) is scheduled to report second-quarter 2017 results after the closing bell on Jul 20.
Why Does Intuitive Surgical Score as a Strong Buy Right Now
by Zacks Equity Research
Over the last three months, Intuitive Surgical Inc. (ISRG) was trading consistently ahead of the S&P 500 Index.
The Fed in the Main Circus Tent: Global Week Ahead
by John Blank
On Wednesday, a two-day Federal Open Market Committee (FOMC) meeting produces a 2 pm ET statement. This will be accompanied by fresh forecasts. Consensus expects a 25 basis point rate hike.
Analyst Reports for GM, VMware and Southwest Airlines
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including General Motors (GM), VMware (VMW), and Southwest Airlines (LUV).
Intuitive Surgical da Vinci X Surgical System Okayed by FDA
by Zacks Equity Research
Headquartered in Sunnyvale, CA, Intuitive Surgical Inc. (ISRG) recently announced that the da Vinci X Surgical System, an upgrade to its flagship da Vinci Xi surgical platform, has been cleared by the FDA.
Intuitive Surgical at 52-Week High: What's Driving the Stock?
by Zacks Equity Research
Share price of Sunnyvale, CA-based Intuitive Surgical Inc (ISRG) scaled a new 52-week high of $874.54 on May 19, eventually closing a bit lower at $870.33.
Why Is Intuitive Surgical (ISRG) Up 5.4% Since the Last Earnings Report?
by Zacks Equity Research
Intuitive Surgical (ISRG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Intuitive Surgical: Q1 Solid, Procedures Likely to Slow Ddown
by Zacks Equity Research
On Apr 21, we issued an updated research report on Sunnyvale-based Intuitive Surgical (ISRG) -- manufacturer of the da Vinci surgical system (an advanced robot-assisted surgical system) and related instruments and accessories.
After ISRG Q1 Earnings, 3 Medical Instrument Stocks Looking Up
by Zacks Equity Research
While the Medical Instrument industry has been oscillating between hope and despair, let us take a look at three stocks which are expected to put up an impressive show this earnings season like Intuitive Surgical.
Intuitive Surgical (ISRG) Beats on Q1 Earnings & Revenues
by Zacks Equity Research
Intuitive Surgical Inc.(ISRG) posted adjusted earnings of $4.67 per share in the first quarter of 2017, crushing the Zacks Consensus Estimate of $3.97 on stellar revenue growth.
Should You Make a Bet on the Healthcare Stocks?
by Tracey Ryniec
The healthcare industry is much more than Obamacare and drug prices as many companies are using new technologies to create breakthroughs in medicine.
Will Intuitive Surgical (ISRG) Surprise in Q1 Earnings?
by Zacks Equity Research
Intuitive Surgical Inc. (ISRG) is scheduled to report first-quarter 2017 results after the closing bell on Apr 18.
Why Is Intuitive Surgical (ISRG) Up 4.6% Since the Last Earnings Report?
by Zacks Equity Research
Intuitive Surgical (ISRG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Intuitive Surgical Hits 52-Week High on Multiple Positives
by Zacks Equity Research
Shares of leading provider of robotic-assisted surgery, Intuitive Surgical, Inc. (ISRG) rallied to a new 52-week high of $770.28 on Mar 28, closing a tad lower at $764.47.
Intuitive Surgical (ISRG) Beats on Q4 Earnings & Revenues
by Zacks Equity Research
Intuitive Surgical Inc. (ISRG) posted adjusted earnings of $5.30 per share in the fourth quarter of 2016, beating the Zacks Consensus Estimate by four cents.
Should You Buy Intuitive Surgical (ISRG) Ahead of Earnings?
by Zacks Equity Research
Intuitive Surgical (ISRG) looks like an exciting pick for investors as it is poised to beat at earnings season.